Editor's Highlights: September 2024

    August 2024 in “ International Journal of Dermatology ”
    Lajos Kemény
    Image of study
    TLDR New therapies and treatments for hair disorders, especially in curly hair, show promise.
    The September 2024 issue of the Journal addresses the unique challenges of diagnosing and treating hair disorders in individuals with curly hair. It explores whether glucagon-like peptide-1 agonists affect hair loss and introduces a novel therapy using adipose stem cell-derived exosomes to stimulate hair growth. The issue also reviews treatment options for filler-induced alopecia and folliculitis decalvans, highlighting recent advancements in these areas.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    3 / 3 results

      community Will Pp405 be the Ozempic of bald Guys

      in Research/Science  104 upvotes 1 week ago
      PP405 is being discussed as a potential hair loss treatment, possibly more effective than minoxidil. There are concerns about its effectiveness and product contamination, but some users report early signs of hair regrowth.

      community Gyno & testoterone level

      in Finasteride  282 upvotes 1 year ago
      Switching from finasteride to dutasteride and back to finasteride led to gynecomastia and fatigue, likely due to hormonal imbalances. Suggested treatments include Tamoxifen, Raloxifene, or low-dose Anastrozole, with a recommendation to test testosterone and estradiol levels.

    Related Research

    6 / 6 results